Alnylam Pharmace. buy Biotechhunter
Start price
20.05.20
/
50%
€130.48
Target price
26.06.20
-
Performance (%)
6.53%
End price
26.06.20
€139.00
Summary
This prediction ended on 26.06.20 with a price of €139.00. With a performance of 6.53%, the BUY prediction by Biotechhunter for Alnylam Pharmace. closed with a slight gain. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 6.498% | 6.498% | -1.582% | 53.247% |
| iShares Core DAX® | 4,37 % | 4,83 % | 8,17 % | 63,26 % |
| iShares Nasdaq 100 | -0,29 % | 3,31 % | 34,82 % | 89,24 % |
| iShares Nikkei 225® | -0,47 % | 8,53 % | 62,39 % | 83,27 % |
| iShares S&P 500 | 1,27 % | 2,86 % | 25,64 % | 68,04 % |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.